缩写名/全名 |
ANN HEPATOL
Annals of Hepatology |
||||||||||||||||
ISSN号 | 1665-2681 | ||||||||||||||||
研究方向 | 医学-胃肠肝病学 | ||||||||||||||||
影响因子 | 2015:1.816, 2016:1.678, 2017:1.576, 2018:1.895, 2019:2.125, | ||||||||||||||||
出版国家 | MEXICO | ||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||
年文章数 | 131 | ||||||||||||||||
出版年份 | 2002 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||
录用比例 | 较易 | ||||||||||||||||
投稿链接 | http://www.editorialmanager.com/annhepatol/default.aspx | ||||||||||||||||
投稿官网 | http://annalsofhepatology.com/ | ||||||||||||||||
h-index | 44 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1665-2681%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Plasma transfusion combined with chelating therapy alleviates fulminant Wilson's disease with a single Arg778Leu heterozygote mutation. Author: Liu L1, Gong Q2, Liu J2, Shen H1, Zhang H1, Xue Y3. Journal: Ann Hepatol. 2019 Mar - Apr;18(2):393-396. doi: 10.1016/j.aohep.2018.07.001. Epub 2019 Apr 12. PubMed DOI |
2. | Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155. Author: Zhang Y1, Li X2, Zhang Y3, Wang L3, Xu J3, Du J3, Guan Y2. Journal: Ann Hepatol. 2019 May - Jun;18(3):494-500. doi: 10.1016/j.aohep.2018.11.007. Epub 2019 Apr 18. PubMed DOI |
3. | Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population. Author: Li Y1, Wang J1, Han X1, Hu H1, Wang F1, Yu C1, Yuan J1, Yao P1, Li X2, Yang K2, Miao X1, Wei S1, Wang Y1, Chen W1, Liang Y1, Zhang X1, Guo H1, Yang H2, Wu T1, He M3. Journal: Ann Hepatol. 2019 Mar - Apr;18(2):298-303. doi: 10.1016/j.aohep.2017.02.001. Epub 2019 Apr 18. PubMed DOI |
4. | Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China. Author: Xu M1, Li Y2, Zhang S1, Wang X1, Shen J1, Zhang S1. Journal: Ann Hepatol. 2019 May - Jun;18(3):456-460. doi: 10.1016/j.aohep.2018.10.005. Epub 2019 Apr 15. PubMed DOI |
5. | RUCAM-based assessment of liver injury by xiang-tian-guo (Swietenia macrophylla) seeds, a plant used for treatment of hypertension and diabetes. Author: Tan Y1, Chen H2, Zhou X3, Sun L3. Journal: Ann Hepatol. 2019 Mar - Apr;18(2):406-407. doi: 10.1016/j.aohep.2019.01.003. Epub 2019 Apr 15. PubMed DOI |
6. | Prognostic value of hepatic encephalopathy for survival of patients with liver failure: A systematic review and meta-analysis. Author: Yu H1, Chen Y1, Jiang P2. Journal: Ann Hepatol. 2019 May 9. pii: S1665-2681(19)30058-4. doi: 10.1016/j.aohep.2019.01.006. [Epub ahead of print] PubMed DOI |
7. | miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice. Author: Liang Q1, Chen H2, Xu X2, Jiang W3. Journal: Ann Hepatol. 2019 Jan - Feb;18(1):116-125. doi: 10.5604/01.3001.0012.7902. PubMed DOI |
8. | Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure. Author: Lu J1, Lin L2, Ye C1, Tao Q1, Cui M1, Zheng S1, Zhu D1, Liu L1, Xue Y3. Journal: Ann Hepatol. 2019 Jan - Feb;18(1):155-164. doi: 10.5604/01.3001.0012.7907. PubMed DOI |
9. | Primary Adenoid Cystic Carcinoma of the Liver: Case Report and Review of the Literature. Author: Zhang J1, Wang Y2, Cao D3. Journal: Ann Hepatol. 2019 Jan - Feb;18(1):209-214. doi: 10.5604/01.3001.0012.7915. PubMed DOI |
10. | Type II Abernethy Malformation in a Patient with Primary Budd-Chiari Syndrome. Author: Ding PX1, Han XW2, Liu C2. Journal: Ann Hepatol. 2019 Jan - Feb;18(1):246-249. doi: 10.5604/01.3001.0012.7933. PubMed DOI |
|
|